不用本金就能赚钱的方法

来宝网Logo

热门词:生物显微镜 水质分析仪 微波消解 荧光定量PCR 电化学工作站 生物安全柜

现在位置不用本金就能赚钱的方法>技术资料不用本金就能赚钱的方法>行业动态>公司动态>日东电工株式会社收购美国核酸药物生产和开发服务公司Avecia Biotechnology

日东电工株式会社收购美国核酸药物生产和开发服务公司Avecia Biotechnology

Nitto Denko Corporation2011年2月10日 17:42 点击:2368

日本日东电工Nitto Denko

日东电工株式会社收购美国核酸药物生产和开发服务公司Avecia Biotechnology
 

此举扩大了公司在新兴核酸药物市场的业务基础

RIBENDABAN--(MEIGUOSHANGYEZIXUN)--RIBENLINGXIANDEDUOYUANHUACAILIAOSHENGCHANSHANGRIDONGDIANGONGZHUSHIHUISHEJINTIANXUANBU,GAIGONGSIYITONGGUOQISHEZAIXINZEXIZHOUTeaneckDEQUANZIZIGONGSINitto Americas, Inc.GONGSISHOUGOULEAvecia Biotechnology, Inc.GONGSI。

不用本金就能赚钱的方法Avecia BiotechnologyGONGSIWEIYUMASAZHUSAIZHOUMilford,SHIHESUANYAOWUSHENGCHANHEKAIFAFUWULINGYUGONGRENDELINGXIANZHE。AveciaGONGSIWEIKEHUTIGONGJIYUDNAHERNADEYAOWUCONGLINCHUANGQIANZHISHANGSHIGEJIEDUANDEFUWU。CHULEcGMP (XIANXINGYAOPINSHENGCHANZHILIANGGUANLIGUIFAN) SHENGCHAN, AveciaGONGSIDEFUWUHAIBAOKUOFENXIFANGFADEKAIFA、GONGYIYANZHENG、WENDINGXINGYANJIU、PINZHIKONGZHIHEFAGUIZHICHI。RIDONGDIANGONGKANHAOHESUANYAOWUGONGYEJUDADEZENGZHANGQIANLI,YIZAITONGGUOCICISHOUGOUJIAQIANGQIZAIGAILINGYUDEYEWUJICHU。

不用本金就能赚钱的方法Avecia BiotechnologyGONGSISHIHESUANYAOWUHETONGSHENGCHANHEXIANGGUANFUWUSHICHANGDELINGXIANZHE,ZAIDAGUIMOSHENGCHANFANGMIANYONGYOUWUKEBINIDELISHIJILU,ZAIZHONGLEIGUANGFANDEHESUANAPI(HUOXINGYAOWUCHENGFEN)FANGMIANYONGYOUGUANGBODEZHUANYEZHISHI。CICISHOUGOUTIXIANLERIDONGDIANGONGDUIHESUANYAOWUGONGYEDEZHONGDACHENGNUO。RIDONGDIANGONGJIANGFAHUIYUAvecia BiotechnologyGONGSIZAIXIALIEFANGMIANDEXIETONGXIAOYING,JINYIBUKUOZHANQIZAIGAILINGYUDEYEWU:

不用本金就能赚钱的方法1. ZAISHICHANGDIWEIHEKEHUGUANXIFANGMIANDEQIANGSHIHUBUXING

2. ZHISHICHANQUANHEJISHU(BAOKUOGEZHONGJIYAOJISHU)FANGMIANDELIANHE

3. GAIJINHESUANSHENGCHANXIAOLV、JIANGDIRIDONGDIANGONGZHUANLIGUTIJUHEWUZHICHIJISHUDESHANGPINCHENGBEN

4. AveciaGONGSIDEDIDUANYOUSHIHEJINXINGKUOZHANGDEKENENGXING,YIQICONGKEHUDELIYICHUFAZENGJIAFUWUXIANGMU

日东电工在核酸药物领域的业务发展

不用本金就能赚钱的方法HESUANYAOWUSHIJUYOUJIDINGHUAXUEJIEGOU(XULIE)DEDUANPIANDUAN。YANJIUXIANSHI,CILEIHUAHEWUNENGGOUYIGAODUTEYIXINGDEFANGSHIYOUXIAODIAOKONGJIYINBIAODA。YINCI,HESUANYAOWUYOUWANGCHENGWEIYONGYUCHUANTONGYAOWUNANYIGONGKEDEGELEIJIBINGDEXINYAO。

不用本金就能赚钱的方法RIDONGDIANGONGPINGJIEQIZAIJIAZHOUOceansideDEQUANZIZIGONGSINitto Denko Technical CorporationZAOYIHUOYUEYUHESUANYAOWUJISHULINGYU。NDTMUQIANZHENGZAIKUODAQIHESUANYAOWUHUAXUEHECHENGDEJISHUKAIFA。

SHOUGOUAvecia BiotechnologyGONGSIYIHOU,RIDONGDIANGONGJIANGFAHUIXINZENGDEHESUANYAOWUHETONGSHENGCHANYEWUNENGLI,JINYIBUKUODAQIZAIGAIYAOWUJISHULINGYUDEYEWUJICHU。

[关于AVECIA BIOTECHNOLOGY INC.公司]

Avecia Biotechnology Inc.GONGSISHIYIJIAYAOWUKAIFAHESHENGCHANFUWUQIYE,WEIYUMASAZHUSAIZHOUMilford。GAIGONGSISHIJIYUDNAHERNADEYAOWUDEGONGYIKAIFA、SHENGCHANHEXIANGGUANFUWULINGYUGONGRENDELINGXIANZHE,ZAIMilfordSHEYOUSHIJIESHANGZUIDADECHENGSHUSHENGCHANSHESHI,NENGGOUYUZHULIUZHIYAOGONGSIHECHUANGXINXINGSHENGWUJISHUGONGSICHENGGONGXIEZUO。ZAIJIYUDNAHERNADECHUANGXINYAOWUFANGMIAN,GONGSINENGTIGONGCONGLINCHUANGQIANCESHIZHISHANGYESHANGSHIHOUGEGEJIEDUANDEFUWU。

进一步信息,请访问.

[关于日东电工株式会社]

RIDONGDIANGONGZHUSHIHUISHECHUANGLIYU1918NIAN,SHIRIBENLINGXIANDEDUOYUANHUACAILIAOSHENGCHANSHANG,WEIQUANQIUSHICHANGTIGONGYUE13,500ZHONGGAOFUJIAZHICHANPIN。RIDONGDIANGONGDEQIANGXIANGZAIYUQINENGCHONGFENLIYONGQIHEXINJISHU,ZHURUJUHEWUHECHENG、ZHANHEHETUCENGJISHU,WEIBOPIAN、BOMOHEQITACAILIAOLINGHUODITIANJIAGEZHONGJINENG。RIDONGDIANGONGZHUSHIHUISHEYONGYOUGUANGFANDEZHUANZHANG,BAOKUOYONGYUYEJINGXIANSHIQIDEGUANGXUEBOMO、QICHECAILIAO、YONGYUHAISHUITUOYANDEFANSHENTOUMO、TOUPIJIYAOTIEPIANDENGDENG。2009CAINIANJINGXIAOSHOUZONGEWEI64YIMEIYUAN,ZAI27GEGUOJIAYONGYOU31,000DUOWEIYUANGONG。

进一步信息,请访问: .

不用本金就能赚钱的方法MIANZESHENGMING:BENGONGGAOZHIYUANWENBANBENNAIGUANFANGSHOUQUANBANBEN。YIWENJINGONGFANGBIANLEJIEZHIYONG,FANQINGCANZHAOYUANWEN,YUANWENBANBENNAIWEIYIJUFALVXIAOLIZHIBANBEN。

联系方式:

日东电工株式会社
Kazuhito Kouno, Rie Miura
Corporate Communications Department
Corporate Sector
电话: +81-6-6452-2215
传真: +81-6-6452-3316
电子邮件发送至: communication_group@nitto.co.jp

 

2011.02.04

不用本金就能赚钱的方法Japan’s leading diversified materials manufacturer, Nitto Denko Corporation, today announced that it has acquired Avecia Biotechnology, Inc. through Nitto Americas, Inc., a wholly owned subsidiary in Teaneck, New Jersey.

Located in Milford, Massachusetts, Avecia Biotechnology is a recognized leader in therapeutic nucleic acid manufacturing and development services. Avecia provides services for DNA and RNA based therapeutics to customers from pre-clinical through commercial launch. In addition to cGMP (current Good Manufacturing Practices) manufacturing, Avecia’s services include the development of analytical methods, process validation, stability studies, quality control, and regulatory support. Nitto Denko aims to strengthen its business base in the domain of nucleic acid drugs with this acquisition, in light of the industry’s great growth potential.

With an unmatched track record in large scale manufacturing and extensive expertise across a broad range of nucleic acid APIs (active pharmaceutical ingredients), Avecia Biotechnology is the market leader in contract manufacturing and related services for nucleic acid drugs. This acquisition represents a significant commitment by Nitto Denko to the nucleic acid drug industry. Nitto Denko will further expand its business in this industry by leveraging the following synergies with Avecia Biotechnology:

1. Strong complementary market positions and client relationships

2. Combined IP and technologies, including drug delivery technologies

3. Improved nucleic acid manufacturing efficiencies and cost of goods with Nitto Denko’s proprietary solid polymer support technology

4. Avecia’s prime location and expansion possibilities to grow the service offering for the benefit of our clients

Nitto Denko’s business development in the domain of nucleic acid drugs

Therapeutic nucleic acid drugs are short fragments of nucleic acids with defined chemical structure (sequence). These compounds have been shown to be effective in the modulation of gene expression in a highly specific manner. As a result, therapeutic nucleic acid drugs have the potential to serve as a novel therapy for various illnesses which conventionally have been difficult to combat.

Nitto Denko already is active in nucleic acid drug technology with its wholly owned subsidiary Nitto Denko Technical Corporation in Oceanside, California. NDT is currently expanding its technological development of the chemical synthesis of nucleic acid drugs.

不用本金就能赚钱的方法 With the acquisition of Avecia Biotechnology, Nitto Denko will further boost its business base in this drug technology domain by leveraging the additional contract manufacturing business of nucleic acid drugs.

ABOUT AVECIA BIOTECHNOLOGY INC.

Avecia Biotechnology Inc. is a drug development and manufacturing service company located in Milford, MA. The company is a recognized leader in process development, manufacturing and related services for DNA and RNA based therapeutics and offers in Milford the world's largest established manufacturing capacity to work successfully with major pharmaceutical and innovative biotechnology companies. All services are offered from preclinical testing to post commercial launch of innovative DNA and RNA based therapeutics.
For additional information, please visit:

ABOUT NITTO DENKO CORPORATION

Founded in 1918, Nitto Denko, Japan’s leading diversified materials manufacturer offers to the global market about 13,500 species of high-value-added products. Nitto Denko’s strength lies in its flexibility to add diverse functionality to sheets, films and other materials, fully utilizing its core technologies such as polymer synthesis, adhesion and coating technologies. The Nitto Denko group’s wide spectrum of specialities include optical films for liquid crystal displays, automotive materials, reverse osmosis membranes for seawater desalination, transdermal drug delivery patches, and much more. Total net sales in FY 2009 was $6.4 billion with over 31,000 employees in 27 countries.
For additional information, please visit:

Contact

Nitto Denko Corporation
Kazuhito Kouno, Rie Miura
Corporate Communications Department
Corporate Sector
Tel : +81-6-6452-2215
Fax : +81-6-6452-3316
E-mail to: communication_group@nitto.co.jp

(来源: Nitto Denko Corporation )


全年征稿 / 资讯合作

联系邮箱:kefu@strauss-usa.com

BANQUANYUMIANZESHENGMING

  • 凡本网注明“来源:来宝网”的所有作品,版权均属于来宝网,转载请必须注明来宝网, http://strauss-usa.com,违反者本网将追究相关法律责任。
  • 本网转载并注明自其它来源的作品,目的在于传递更多信息,并不代表本网赞同其观点或证实其内容的真实性,不承担此类作品侵权行为的直接责任及连带责任。其他媒体、网站或个人从本网转载时,必须保留本网注明的作品来源,并自负版权等法律责任。
  • 如涉及作品内容、版权等问题,请在作品发表之日起一周内与本网联系,否则视为放弃相关权利。


湖南快乐十分 湖南快乐十分 福建快3走势图0 福建快3走势图 河南快3走势图 河南快3走势图 广东11选5开奖结果 福建11选5走势图